Page last updated: 2024-10-26
dipyridamole and Bruise
dipyridamole has been researched along with Bruise in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kalowski, S | 1 |
| Kincaid-Smith, P | 1 |
Other Studies
1 other study available for dipyridamole and Bruise
| Article | Year |
|---|---|
Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
Topics: Adolescent; Adult; Contusions; Dipyridamole; Drug Interactions; Epistaxis; Female; Glomerulonephriti | 1973 |